InsidersTradesSigma
Follow the OCULAR THERAPEUTIX, INC. share price and the full management transaction log of the company, a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). The latest transaction was disclosed on 3 June 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: NADIA K. WAHEED. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
OCULAR THERAPEUTIX, INC. is a biopharmaceutical company focused on developing innovative treatments for eye diseases. It is listed on the NASDAQ under the symbol OCUL.